Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plaza
Suite 310
Los Angeles, CA 90095Phone+1 310-267-7794Fax+1 310-267-7794
Summary
- Dr. James Wu is an endocrine surgeon (thyroid, parathyroid, adrenal) in Los Angeles, CA. He is currently affiliated with UCLA Medical Center, UCLA Medical Center-Santa Monica, and Olive View Medical Center.
James received his medical degree from University of Colorado, then completed his General Surgery residency at UCLA. He also finished a Head & Neck Surgery fellowship at Memorial Sloan Kettering Cancer Center in NYC.
James specializes in surgery for thyroid cancer, parathyroid disease, and adrenal surgery. He is a professional member of the American Thyroid Association and American Association of Endocrine Surgeons.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Surgery, 2019
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2011 - 2018
- Memorial Sloan Kettering Cancer CenterResidency, Surgery, 2017
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2011
- Cornell UniversityBA, Chemistry and Chemical Biology, 2002 - 2006
Certifications & Licensure
- CA State Medical License 2013 - 2027
- NY State Medical License 2017 - 2019
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Emergency Med Consultant Award Nominee UCLA SOM, 2016
- Outstanding Student Teacher Award UCLA SOM, 2014
- Alpha Omega Alpha University of Colorado SOM, 2011
- Join now to see all
Clinical Trials
- Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer Start of enrollment: 2020 Feb 21
Roles: Principal Investigator, Contact
- Postoperative Opt-In Narcotics Treatment in Breast Start of enrollment: 2022 Jun 01
Roles: Contact, Principal Investigator
- Mapping Patient Decision-making in Thyroid Cancer Start of enrollment: 2025 Jan 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma.Harvey K Chiu, Theodore S Nowicki, Masha J Livhits, James X Wu, Noah Federman
Journal of Pediatric Endocrinology & Metabolism. 2024-11-26 - 1 citationsNational Trends and Outcomes in the Operative Management of Thyroid Storm.Young-Ji Seo, Nikhil Chervu, Peyman Benharash, James X Wu
The American Surgeon. 2024-10-01 - From Bench-to-Bedside: How Artificial Intelligence is Changing Thyroid Nodule Diagnostics, a Systematic Review.Vivek R Sant, Ashwath Radhachandran, Vedrana Ivezic, Denise T Lee, Masha J Livhits
The Journal of Clinical Endocrinology and Metabolism. 2024-06-17
Journal Articles
- More Extensive Surgery May Not Improve Survival Over Parathyroidectomy Alone in Parathyroid CarcinomaYoung S, Wu JX, Li N, Yeh MW, Livhits MJ, Annals of Surgical Oncology, 1/1/2016
- Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid NodulesWu JX, Young S, Hung M, Li N, Yang SE, Cheung DS, Yeh MW, Livhits MJ, Thyroid, 1/1/2016
- Metformin Restrains Pancreatic Duodenal Homeobox-1 Function by Inhibiting ERK Signaling in Pancreatic AdenocarcinomaZhou G, Yu J, Wang A, Liu SH, Sinnett-Smith J, Wu J, Sanchez R, Nemunaitis J, Ricordi C, Rozengurt E, Brunicardi FC, Current Molecular Medicine, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Patient willingness to participate in a US randomized controlled trial for nonoperative management of uncomplicated appendicitis.Yan H, Lee SL, Krishnadasan A, Brunicardi FC, DeUgarte DA, Katkhouda N, McPheeters R, Salem R, Wu JX, Talan DA, Journal of American College of Surgeons, 1/1/2015
- Over-expression of human SSTR5 in murine insulinoma cells potentiates response to somatostatin receptor agonists compared to hypofunctional mutation SSTR5L335Wu JX, Liu SH, Zhou GS, Yu J, Sanchez R, Brunicardi FC, American Pancreatic Association, Kohala Coast, HI, 1/1/2014
Lectures
- Impact of Malignancy Rates on Cost-Effectiveness of Routine GEC Testing for Indeterminate Thyroid NodulesNashville, TN - 1/1/2015
- Cost-effectiveness analysis of non-operative management for acute uncomplicated appendicitis.Las Vegas, NV - 1/1/2015
- Can it wait until morning? A comparison of nighttime vs daytime cholecystectomy for acute cholecystitisScottsdale, AZ - 1/1/2014
- Join now to see all
Other
- A Flaw in the Care of Cancer PatientsWu JX, KevinMD.com
http://www.kevinmd.com/blog/
1/1/2016 - You should want surgery residents for your operation. Here’s why.Wu JX, KevinMD.com
http://www.kevinmd.com/blog/
1/19/2016 - Reflections on AAS fall coursesWu JX, The Academic Surgeon: The official blog of the AAS
http://www.aasurg.org/blog/
1/30/2013 - Join now to see all
Press Mentions
- Journal Review in Endocrine Surgery: How Dr. Yeh Built ItNovember 7th, 2022
- Clinical Challenges in Endocrine Surgery: Medullar Thyroid Cancer with Special Guest Dr. Kepal PatelJune 20th, 2022
- Journal Review Endocrine Surgery: AAES 2021 HighlightsJuly 12th, 2021
Professional Memberships
- Member
- American Association of Endocrine SurgeonsMember
External Links
- Blog http://backto.thesuture.net
- Google Scholar Profilehttps://scholar.google.com/citations?hl=en&user=3U3DQ2cAAAAJ
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: